Background Catheter ablation improves ventricular tachycardia (VT) event-free (time to
event) survival in patients with antiarrhythmic drug (AAD)-refractory VT and previous …

Background The VANISH trial (Ventricular Tachycardia Ablation Versus Escalated
Antiarrhythmic Drug Therapy in Ischemic Heart Disease) compared the effectiveness of …

Aims Catheter ablation is superior to escalated antiarrhythmic drugs among patients with
ventricular tachycardia (VT) and prior myocardial infarction (MI). However, it is uncertain …

Background Recurrent ventricular tachycardia (VT) in patients with prior myocardial
infarction is associated with adverse quality of life and clinical outcomes, despite the …

Background: Catheter ablation for ventricular tachycardia (VT) reduces the recurrence of VT
in patients with implantable cardioverter-defibrillators (ICDs). The appropriate timing of VT …

Background In patients with ischemic cardiomyopathy and an implantable cardioverter-
defibrillator (ICD), catheter ablation and antiarrhythmic drugs (AADs) reduce ICD shocks, but …

Background Recurrent ventricular tachycardia among survivors of myocardial infarction with
an implantable cardioverter–defibrillator (ICD) is frequent despite antiarrhythmic drug …

Ventricular tachycardia(VT) occurs most frequently in patients with structural heart disease,
and implantable cardioverter defibrillators (ICDs) have been clearly shown to improve …

Background The optimal timing of catheter ablation for the treatment of ventricular
tachycardia (VT) in patients with ischemic cardiomyopathy remains unclear. Studies …

Catheter Ablation for Ventricular Tachycardia Introduction We conducted this pilot
randomized clinical trial to determine the feasibility of a large clinical trial aimed at testing …